Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Michael Saccente

Concepts (110)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Histoplasmosis
2
2021
50
0.960
Why?
Acquired Immunodeficiency Syndrome
3
2021
54
0.830
Why?
Lymphogranuloma Venereum
1
2022
1
0.810
Why?
Proctocolitis
1
2022
1
0.810
Why?
Pneumonia, Pneumocystis
1
2021
6
0.790
Why?
Pneumocystis carinii
1
2021
4
0.790
Why?
beta-Glucans
1
2021
23
0.780
Why?
Inflammatory Bowel Diseases
1
2022
53
0.760
Why?
Sweet Syndrome
1
2021
10
0.750
Why?
Mycobacterium Infections, Nontuberculous
1
2021
20
0.740
Why?
Antifungal Agents
4
2008
339
0.680
Why?
Citrus paradisi
2
2008
10
0.540
Why?
Food-Drug Interactions
2
2008
14
0.540
Why?
Itraconazole
2
2008
40
0.540
Why?
HIV Infections
3
2006
357
0.490
Why?
Blastomyces
1
2010
31
0.350
Why?
Blastomycosis
1
2010
62
0.350
Why?
Beverages
2
2008
56
0.310
Why?
Candida
1
2008
60
0.300
Why?
Arthritis, Infectious
1
2008
45
0.290
Why?
Candidiasis
1
2008
114
0.290
Why?
Anti-Retroviral Agents
1
2006
14
0.280
Why?
Mycobacterium fortuitum
1
2006
6
0.270
Why?
Joint Diseases
1
2006
41
0.260
Why?
Tuberculosis
2
2009
146
0.250
Why?
Patient Compliance
1
2006
230
0.250
Why?
beta-Cyclodextrins
1
2004
16
0.240
Why?
Prosthesis-Related Infections
1
2006
105
0.230
Why?
Humans
18
2022
50208
0.230
Why?
Amphotericin B
1
2003
110
0.210
Why?
Male
11
2022
25398
0.210
Why?
Glucans
1
2021
10
0.200
Why?
Tuberculin Test
1
2001
9
0.200
Why?
Homosexuality, Male
1
2022
51
0.190
Why?
Adult
9
2021
13325
0.190
Why?
Infectious Disease Transmission, Vertical
1
2000
15
0.180
Why?
Autoantibodies
1
2021
116
0.180
Why?
Interferon-gamma
1
2021
176
0.180
Why?
Cat-Scratch Disease
1
1999
7
0.180
Why?
Liver Abscess
1
1999
5
0.180
Why?
Retinitis
1
1999
5
0.180
Why?
Meningitis
1
1999
24
0.170
Why?
Optic Neuritis
1
1999
21
0.170
Why?
Klebsiella Infections
1
1999
12
0.170
Why?
Klebsiella pneumoniae
1
1999
20
0.170
Why?
Facial Paralysis
1
1999
24
0.170
Why?
Vancomycin Resistance
1
2019
5
0.170
Why?
Endophthalmitis
1
1999
25
0.170
Why?
Chronic Disease
1
2022
571
0.170
Why?
Diabetes Complications
1
1999
119
0.160
Why?
Vancomycin
1
2019
81
0.160
Why?
Macrophages
1
2019
363
0.140
Why?
Pharmaceutical Solutions
2
2008
8
0.140
Why?
Staphylococcal Infections
1
2019
269
0.130
Why?
Area Under Curve
2
2008
178
0.130
Why?
Staphylococcus aureus
1
2019
327
0.130
Why?
Cross-Over Studies
2
2008
218
0.130
Why?
Anti-Bacterial Agents
1
2019
747
0.110
Why?
Female
8
2010
26634
0.110
Why?
Ixodes
1
2010
6
0.090
Why?
Arthroplasty, Replacement, Knee
2
2006
284
0.090
Why?
Lyme Disease
1
2010
32
0.090
Why?
Borrelia burgdorferi
1
2010
31
0.090
Why?
Retrospective Studies
1
2021
6134
0.080
Why?
Pancreatic Diseases
1
2009
15
0.080
Why?
AIDS-Related Opportunistic Infections
1
2009
40
0.080
Why?
Drug Resistance, Fungal
1
2008
31
0.080
Why?
Cytochrome P-450 CYP3A
1
2008
78
0.070
Why?
Administration, Oral
1
2008
434
0.070
Why?
Sex Factors
1
2008
697
0.060
Why?
Cyclodextrins
1
2004
18
0.060
Why?
Critical Illness
1
2006
288
0.060
Why?
Biological Availability
1
2004
96
0.060
Why?
Middle Aged
4
2009
12206
0.060
Why?
Burkholderia
1
2002
11
0.050
Why?
Ultrasonics
1
2002
31
0.050
Why?
Staphylococcus
1
2002
35
0.050
Why?
Fatal Outcome
1
2003
195
0.050
Why?
Knee Prosthesis
1
2002
51
0.050
Why?
Hip Prosthesis
1
2002
71
0.050
Why?
Biofilms
1
2002
181
0.050
Why?
Scotoma
1
1999
7
0.040
Why?
Fundus Oculi
1
1999
25
0.040
Why?
Arkansas
2
2010
1984
0.040
Why?
Visual Field Tests
1
1999
13
0.040
Why?
Lysostaphin
1
2019
1
0.040
Why?
Multilocus Sequence Typing
1
2019
14
0.040
Why?
Aged
3
2019
9405
0.040
Why?
Daptomycin
1
2019
29
0.040
Why?
Cell Wall
1
2019
55
0.040
Why?
Prenatal Care
1
2000
109
0.040
Why?
Arthroplasty, Replacement, Hip
1
2002
262
0.040
Why?
Bacteremia
1
2019
92
0.040
Why?
Microbial Sensitivity Tests
1
2019
270
0.040
Why?
Mass Screening
1
2000
346
0.040
Why?
Incidence
1
2000
1006
0.040
Why?
Mutation
1
2019
1294
0.030
Why?
Infant, Newborn
1
2000
2765
0.030
Why?
Pregnancy
1
2000
2604
0.030
Why?
Risk Factors
1
2000
3629
0.020
Why?
Antiretroviral Therapy, Highly Active
1
2009
34
0.020
Why?
HIV-1
1
2009
55
0.020
Why?
Adolescent
1
2000
6390
0.020
Why?
Antitubercular Agents
1
2009
106
0.020
Why?
Mycobacterium tuberculosis
1
2009
285
0.020
Why?
Filtration
1
2002
24
0.010
Why?
Colony Count, Microbial
1
2002
66
0.010
Why?
Prospective Studies
1
2002
2379
0.010
Why?
Aged, 80 and over
1
2002
3154
0.010
Why?
Animals
1
2010
13246
0.010
Why?
Saccente's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description